OABI
NASDAQOmniAb Inc.
Price$2.27-0.21 (-8.28%)
01:30 PM07:45 PM
News · 26 weeks32-100%
2025-12-142026-06-07
Mix1590d
- SEC Filings7(47%)
- Insider5(33%)
- Earnings2(13%)
- Other1(7%)
Latest news
25 items- SECSEC Form 10-Q filed by OmniAb Inc.10-Q - OmniAb, Inc. (0001846253) (Filer)
- SECOmniAb Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - OmniAb, Inc. (0001846253) (Filer)
- PROmniAb Reports First Quarter 2026 Financial Results and Business HighlightsConference Call Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three months ended March 31, 2026, provided operating and partner program updates, and increased 2026 financial guidance. "OmniAb experienced strong momentum during the first quarter as multiple partnered programs advanced into later-stage clinical development, reinforcing the diversity and value of our portfolio. With a very strong start to the year, we are raising our 2026 revenue guidance," stated Matt Foehr, Chief Executive Officer of OmniAb. "Continued progression of partner programs highlights the value of our technology platform and positions our business wel
- SECSEC Form DEF 14A filed by OmniAb Inc.DEF 14A - OmniAb, Inc. (0001846253) (Filer)
- SECSEC Form DEFA14A filed by OmniAb Inc.DEFA14A - OmniAb, Inc. (0001846253) (Filer)
- PROmniAb to Participate in Three Upcoming Investor ConferencesOmniAb, Inc. (NASDAQ:OABI) today announced that management will be participating in three investor conferences over the coming weeks. H.C. Wainwright 2nd Annual Royalty Company Virtual Conference, May 6. Management will participate in a fireside chat on Wednesday, May 6th. Benchmark 6th Annual Healthcare House Call Virtual Investor Conference, May 28. Management will hold virtual one-on-one and small group meetings with investors on Thursday, May 28th. Jefferies Global Healthcare Conference, June 2-4 at the Marriott Marquis in New York City. Management will present a corporate overview on Wednesday, June 3rd at 4:55 p.m. Eastern time and will hold one-on-one meetings with investors
- INSIDERSEC Form 4 filed by Gotwals Philip J4 - OmniAb, Inc. (0001846253) (Issuer)
- INSIDERSEC Form 4 filed by Crouse Steven C.4 - OmniAb, Inc. (0001846253) (Issuer)
- PROmniAb to Report First Quarter 2026 Financial Results on May 7OmniAb, Inc. (NASDAQ:OABI) will report financial results for the three months ended March 31, 2026, after the close of the U.S. financial markets on Thursday, May 7, 2026, and will hold a conference call that same day beginning at 4:30 p.m. Eastern time. Conference Call and Webcast Information What: OmniAb conference call to discuss first quarter 2026 financial results and business updates Date: Thursday, May 7, 2026 Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time) Phone: U.S. (833) 461-5787 Internati
- SECSEC Form 144 filed by OmniAb Inc.144 - OmniAb, Inc. (0001846253) (Subject)
- INSIDERSEC Form 4 filed by Foehr Matthew W4 - OmniAb, Inc. (0001846253) (Issuer)
- SECSEC Form 144 filed by OmniAb Inc.144 - OmniAb, Inc. (0001846253) (Subject)
- INSIDERSEC Form 4 filed by Gustafson Kurt A4 - OmniAb, Inc. (0001846253) (Issuer)
- INSIDERSEC Form 4 filed by Berkman Charles S4 - OmniAb, Inc. (0001846253) (Issuer)
- SECSEC Form 144 filed by OmniAb Inc.144 - OmniAb, Inc. (0001846253) (Subject)
- SECSEC Form 10-K filed by OmniAb Inc.10-K - OmniAb, Inc. (0001846253) (Filer)
- SECOmniAb Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - OmniAb, Inc. (0001846253) (Filer)
- PROmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business HighlightsConference Call Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the quarter and year ended December 31, 2025, and provided operating and partner program updates. "OmniAb exited 2025 with an expanded base of 107 active partners and a growing portfolio of 407 active programs. Our differentiated technologies support our business outlook and allow us to add programs while maintaining a disciplined cost structure. As our partner pipeline continues to advance, several later-stage assets are emerging with potential to generate meaningful milestones and, ultimately, recurring royalty revenue," said Matt Foehr, Chief Executive Officer of Omn
- PROmniAb to Participate at the Leerink Partners Global Healthcare ConferenceOmniAb, Inc. (NASDAQ:OABI) today announced that management will participate at the Leerink Global Healthcare Conference taking place March 8-11, 2026, at the W South Beach in Miami. Management will present a corporate overview on Tuesday, March 10th at 3:40 p.m. Eastern time and will hold one-on-one meetings with investors registered for the event. Investors interested in scheduling a meeting with OmniAb management should contact their Leerink Partners representative, or email LeerinkEvents@Leerink.com. About OmniAb® OmniAb licenses cutting edge discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation th
- PROmniAb to Report Fourth Quarter 2025 Financial Results on March 4OmniAb, Inc. (NASDAQ:OABI) will report financial results for the quarter and year ended December 31, 2025, after the close of the U.S. financial markets on Wednesday, March 4, 2026, and will hold a conference call that same day beginning at 4:30 p.m. Eastern time. Conference Call and Webcast Information What: OmniAb conference call to discuss fourth quarter 2025 financial results and business updates Date: Wednesday, March 4, 2026 Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time) Phone: U.S. (800) 549-8228
- INSIDERChief Legal Officer Berkman Charles S converted options into 18,750 shares and sold $16,541 worth of shares (9,673 units at $1.71), increasing direct ownership by 2% to 392,700 units (SEC Form 4)4 - OmniAb, Inc. (0001846253) (Issuer)
- INSIDERExecutive VP, Finance and CFO Gustafson Kurt A converted options into 18,750 shares and sold $15,905 worth of shares (9,301 units at $1.71), increasing direct ownership by 4% to 268,851 units (SEC Form 4)4 - OmniAb, Inc. (0001846253) (Issuer)
- INSIDERPresident and CEO Foehr Matthew W converted options into 58,333 shares and sold $52,742 worth of shares (30,843 units at $1.71), increasing direct ownership by 0.63% to 4,403,277 units (SEC Form 4)4 - OmniAb, Inc. (0001846253) (Issuer)
- INSIDERPresident and CEO Foehr Matthew W converted options into 36,458 shares and sold $35,282 worth of shares (20,754 units at $1.70), increasing direct ownership by 0.36% to 4,375,787 units (SEC Form 4)4 - OmniAb, Inc. (0001846253) (Issuer)
- INSIDERExecutive VP, Finance and CFO Gustafson Kurt A converted options into 13,542 shares and sold $11,608 worth of shares (6,828 units at $1.70), increasing direct ownership by 3% to 259,402 units (SEC Form 4)4 - OmniAb, Inc. (0001846253) (Issuer)
OABI FAQ
6 questionsWhere does OABI stock trade?
OmniAb Inc. (OABI) is listed on NASDAQ.What sector and industry is OABI in?
OmniAb Inc. operates in the Health Care sector, Biotechnology: Commercial Physical & Biological Resarch industry.When did OmniAb Inc. go public?
OmniAb Inc. (OABI) completed its IPO in 2021.What are analysts saying about OABI?
OmniAb Inc. has had 5 recent analyst actions on file. The most recent action was from RBC Capital Mkts: Outperform with a $600.00 price target on 2023-11-29. Recent price targets range from $600.00 to $1100.00.What companies are similar to OABI?
Notable peers in the same industry include IQV (IQVIA Holdings Inc.), INCY (Incyte Corp.), PPD (PPD, Inc.), MEDP (Medpace Holdings Inc.), ICLR (ICON plc). Compare OABI side-by-side with any of them on Quantisnow.How can I track OABI on Quantisnow?
Quantisnow aggregates OmniAb Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow OABI to receive live email and push alerts on every new disclosure.